Medicines
- OX42g - NHS Prescribing of Gluten Free Foods
- OX088e - Optimising Self Care by appropriate use of Over-the-counter Medicines (Restricted Prescribing List)
- OX160b - Methyphenidate and atomoxetine in Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents
- OX250c - Specialist Infant Formulas
- OX277 - Oral Nutritional Supplements (Adults)
- BOBFPC5 - Anti-VEGF Treatments and Dexamethasone Implants for Macular Oedema caused by Central and Branch Retinal Vein Occlusion
- BOBFPC10 - Interventions for non-union fracture - Low-intensity Pulsed Ultrasound and teriparatide
- TVPC12 - Botulinum Toxin A
- TVPC14 - Biological Mesh
- TVPC25 - Hyperhidrosis (excessive sweating) – Botulinum Toxin A and Endoscopic Thoracic Sympathectomy
- BOBFPC34 - Erectile Dysfunction
- BOBFPC40 - Penile Rehabilitation Following Prostate Surgery
- TVPC43 - Use of biologic therapies and Janus-associated tyrosine kinases (JAK) inhibitors for ulcerative colitis in adults
- TVPC44 - Sequential use of a third or subsequent biologic therapy for psoriasis
- TVPC45 - Sequential use of biologic therapy in Ophthalmology – Interim policy statement
- TVPC46 - Sequential use of biologic therapies and Janus-associated tyrosine kinases (JAK) inhibitors in Psoriatic Arthritis – INTERIM POLICY
- TVPC51 - Use of biological and immunomodulatory therapies in Rheumatoid Arthritis - INTERIM POLICY
- BOBFPC54 - Melatonin treatment in children
- TVPC64 - Real-time continuous glucose monitors for adults with type 1 diabetes
- TVPC65 - Continuous subcutaneous insulin infusion (insulin pumps) for adults with type 1 diabetes
- BOBFPC71 - Treatment Pathway for Adults with Attention Deficit Hyperactivity Disorder (ADHD)
- TVPC81 - Prescribing of cannabis-based medicinal products - Interim Policy
- TVPC87 - Negative Pressure Wound Therapy for wound healing
- TVPC89 - Real-time Continuous Glucose Monitors for Paediatric Patients with Type 1 Diabetes
- TVPC90 - Intravenous Lidocaine infusions for chronic pain
- TVPC92 - Biologic drugs for the management of axial spondyloarthritis
- TVPC92 - Biologic drugs for the management of Crohn’s disease
- BOBFPC95 - Treatment of Chalazia
- TVPC96 - Anti VEGFs for the management of sight threatening rare eye conditions involving neo-vascularisation
- TVPC97 - Immunotherapy for allergic rhinoconjunctivitis
- TVPC99 - Sodium oxybate for narcolepsy with cataplexy in adults
- TVPC103 - Use of biological and immunomodulatory therapies in moderate Rheumatoid Arthritis – INTERIM POLICY
- TVPC111 - Serum P1NP measurement in the management of osteoporosis
- BOBFPC111 - Treatment with Anti-VEGF agents for Neovascular (Wet) Age-Related Macular Degeneration in patients with ‘one good eye’
- TVPC160b - Methyphenidate and atomoxetine in Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents
- TVPC177b - Atomoxetine in Adults with Attention Deficit Hyperactivity Disorder (ADHD)
- TVPC291 - Iron Chelation in Myelodysplastic Syndrome (MDS)